Atlas Trials

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Clinical trial NCT00393822 · COMPLETED

Trial details

NCT number
NCT00393822
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Colon Cancer
Start date
2005-08-01
Primary completion
2007-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.